Literature DB >> 10414490

Vasculopathy of small muscular arteries in pediatric patients after bone marrow transplantation.

D M Selby1, J R Rudzki, E S Bayever, R S Chandra.   

Abstract

Bone Marrow Transplant (BMT) is a critical therapeutic intervention for a variety of diseases occurring in the pediatric patient. Complications of allogeneic BMT include graft-versus-host disease (GVHD), infection, drug toxicity, thrombotic microangiopathy, and veno-occlusive disease. With solid organ transplantation, chronic vascular rejection has emerged as a major factor limiting long-term survival of the graft. We present a vasculopathy of small muscular arteries in 6 patients after allogeneic BMT. Cases include 4 boys and 2 girls ranging in age from 4 months to 13 years with full or partial human leukocyte antigen matching. Five of the 6 transplants were from related donors. The vasculopathy occurred 13 to 418 days after transplant and was noted in surgical specimens (2) and at autopsy (4). It was seen in the gastrointestinal tract and lung in 3 cases each. Vascular changes in small muscular arteries include concentric intimal or medial hyperplasia with luminal narrowing, prominent myxoid change, extravasated red blood cells, and presence of some foamy histiocytes with no evidence of thrombotic microangiopathy. Vasculopathy contributed to intestinal compromise requiring surgical intervention 3 times in 1 patient, and diffuse alveolar damage with hemorrhage in another. All 6 patients are dead. The cause of this unusual vasculopathy present in patients after BMT is likely to be multifactorial, involving effects of irradiation, chemotherapy, cyclosporine, and GVHD. Together these may create a negative synergy which produces an obliterative arteriopathy that should be recognized as a pathological entity and may be a harbinger of a poor prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10414490     DOI: 10.1016/s0046-8177(99)90132-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Glomerular vasculopathy after unrelated cord blood transplantation.

Authors:  Chihaya Imai; Toshio Kakihara; Haruko Iwabuchi; Atsushi Tanaka; Tatsuo Furukawa; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2003-03-21       Impact factor: 3.714

2.  Late-onset gastrointestinal pain in juvenile dermatomyositis as a manifestation of ischemic ulceration from chronic endarteropathy.

Authors:  Gulnara Mamyrova; David E Kleiner; Laura James-Newton; Bracha Shaham; Frederick W Miller; Lisa G Rider
Journal:  Arthritis Rheum       Date:  2007-06-15

3.  Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.

Authors:  N Murase; Q Ye; M A Nalesnik; A J Demetris; K Abu-Elmagd; J Reyes; N Ichikawa; T Okuda; J J Fung; T E Starzl
Journal:  Transplantation       Date:  2000-12-15       Impact factor: 4.939

4.  High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.

Authors:  Tatsuya Adachi; Tadashi Matsushita; Ryoichi Ichihashi; Kanji Hirashima; Masafumi Ito; Akira Inukai; Toshiya Yokozawa; Tetsuya Nishida; Makoto Murata; Mutsuharu Hayashi; Akira Katsumi; Tetsuhito Kojima; Hidehiko Saito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2006-06       Impact factor: 2.490

Review 5.  Reversible course of pulmonary arterial hypertension related to bone marrow transplantation.

Authors:  Alisa Limsuwan; Samart Pakakasama; Suradej Hongeng
Journal:  Heart Vessels       Date:  2011-01-07       Impact factor: 2.037

6.  Cerebral vascular injury in transplant-associated thrombotic microangiopathy.

Authors:  Anthony Sabulski; Grace Arcuri; Sara Szabo; Marguerite M Care; Christopher E Dandoy; Stella M Davies; Sonata Jodele
Journal:  Blood Adv       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.